Overview
UHD is a recently formed multi-million-pound investment Trust comprising Poole Hospital, Royal Bournemouth & Christchurch Hospitals in partnership with Bournemouth University. The 30-bed haematology in-patient unit, including the JACIE-accredited autologous transplant unit, will be housed at the Royal Bournemouth Hospital from April 2024 and will provide day case chemotherapy and outpatient facilities. Poole Hospital is developing as the major planned/elective care hospital with day case chemotherapy and outpatient facilities.
We currently run dedicated CLL, lymphoma, WM, myeloma, MDS & MPN clinics. We have representation on NCRI MDS, MPN, Myeloma & CLL subgroups, and on national bodies including UK Myeloma Society, UK CLL Forum and UK MDS Forum executive committees, and are actively involved in writing BSH national guidelines.
We are recruiting to a Haemato-oncology consultant post (10PA). Applicants wishing to work LTFT will also be considered.
Successful candidates will join our friendly team of haemato-oncology consultants and participate in a 1:13 rota supported by a two-tiered SHO and SpR on-call rota.
We have an active JACIE-accredited transplant centre for Dorset autologous stem cell transplants and network with the University Hospital Southampton transplant team, which provides allogeneic & CART-cell services for our patients.
At UHD we are proud of the services we offer, including access to an extensive clinical trial portfolio and novel treatment delivery approaches with a strong home care & community chemotherapy team. We intend to expand our service and welcome candidates interested in further developing our bispecific antibody programme. We expect all colleagues to take an active role in clinical research and encourage consultants to take on local PI & CI roles in their sub-speciality interests.
We have strong links with Southampton & Bournemouth universities and there is the opportunity for collaborative research. We currently have 1 PhD student based in the Dorset Pathology Hub, which recently opened on the Bournemouth site and houses the Dorset HMDS.
We reserve the right to close this advertisement early if we receive a high volume of suitable applications.
Responsibilities
* Provide haemato-oncology clinical care within UHD, contributing to service development and delivery across the Dorset region.
* Participate in a 1:13 on-call rota supported by a two-tiered SHO/SpR on-call structure.
* Work within the JACIE-accredited transplant centre for autologous stem cell transplants and collaborate with the Southampton transplant team for allogeneic and CART-cell services.
* Engage in research activity, including clinical trials, PI & CI roles, and development of sub-speciality interests (e.g., bispecific antibody programme).
* Collaborate with universities and participate in collaborative research projects and supervision of trainees.
* Contribute to service expansion, home care, and community chemotherapy delivery.
Qualifications and experience
* Appointment as a Haemato-oncology consultant or equivalent.
* Interest in developing research activity and new treatment programmes within the haemato-oncology service.
* Willingness to participate in clinical trials and sub-speciality leadership roles where appropriate.
Benefits and opportunities
Opportunities for collaboration with Southampton and Bournemouth universities, with possible PhD and other research activities. Access to an extensive clinical trial portfolio and home care/community chemotherapy services. Possibility to contribute to the expansion of the bispecific antibody programme.
How to apply and timeline
Start ASAP. This advert closes on Wednesday 8 Oct 2025. For further details relating to the job description and main responsibilities, please refer to the attached documents.
#J-18808-Ljbffr